# Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation

> **NCT07424326** · NA · NOT_YET_RECRUITING · sponsor: **Charles University, Czech Republic** · enrollment: 450 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **PROCEDURE:** PVI-plus
- **PROCEDURE:** PVI-only

## Key facts

- **NCT ID:** NCT07424326
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424326, "Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07424326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
